TY - JOUR
T1 - Exercise Training in Patients With Hypertrophic Cardiomyopathy Without Left Ventricular Outflow Tract Obstruction
T2 - A Randomized Clinical Trial
AU - Gudmundsdottir, Helga
AU - Axelsson Raja, Anna
AU - Rossing, Kasper
AU - Rasmusen, Hanne
AU - Snoer, Martin
AU - Andersen, Lars Juel
AU - Gottlieb, Rikke
AU - Christensen, Alex Hørby
AU - Bundgaard, Henning
AU - Gustafsson, Finn
AU - Thune, Jens Jakob
PY - 2025/1/14
Y1 - 2025/1/14
N2 - BACKGROUND: Patients with hypertrophic cardiomyopathy without left ventricular outflow tract obstruction commonly experience reduced exercise capacity. Physical training improves exercise capacity in these patients, but whether the underlying effects of exercise are a result of central hemodynamic or peripheral improvement is unclear. This study assessed whether exercise training reduces left ventricular filling pressure measured during exercise in patients with hypertrophic cardiomyopathy without left ventricular outflow tract obstruction.METHODS: Between March 2019 and June 2022, patients with hypertrophic cardiomyopathy without left ventricular outflow tract obstruction were randomly assigned (1:1) to a 12-week (3 h/wk) supervised, moderate-intensity exercise training program or continued usual activity. The primary outcome was the change in invasively measured pulmonary capillary wedge pressure during mild exercise (25 W) from baseline to week 12. Pressure tracings were analyzed offline by a blinded investigator. Secondary outcomes included changes in peak oxygen consumption, cardiac index, quality of life, echocardiographic indices of diastolic function, and natriuretic peptides.RESULTS: Of 59 patients randomized (mean age, 58.1 [12.2] years; 27% women), 51 (86%) completed all follow-up assessments. At week 12, the change in 25-W pulmonary capillary wedge pressure was -2.8 (6.8) mm Hg in the exercise group, compared with +1.2 (4.9) mm Hg in the usual-activity group (between-group difference, 4.0 mm Hg [95% CI, 0.7-7.3];
P=0.018). Peak oxygen consumption improved by +1.8 (2.0) mL·kg⁻¹·min⁻¹ in the exercise group versus -0.3 (3.1) mL·kg⁻¹·min⁻¹ in the usual-activity group (
P=0.005). Exercise training improved the ventilatory efficiency (V
E/VCO
2) slope compared with usual activity (between-group difference, 2.0 [95% CI, 0.6-3.5];
P=0.006). Peak cardiac index improved by +0.38 (1.38) L·min⁻¹·m⁻² in exercise versus -0.85 (1.20) L·min⁻¹·m⁻² in the usual-activity group (
P=0.002). Change in overall Kansas City Cardiomyopathy Questionnaire score was similar between groups. However, the change in physical limitation scores (+8.4 [12.0] points in exercise versus +0.7 [6.8] points in usual-activity group;
P=0.034) and quality-of-life scores (+8.7 [18.0] points in exercise versus 0.7 [4.0] points in usual-activity group;
P=0.01) differed significantly. There were no significant changes in diastolic function assessed by echocardiography or in natriuretic peptides.
CONCLUSIONS: In patients with hypertrophic cardiomyopathy without left ventricular outflow tract obstruction, a 12-week moderate-intensity exercise training program resulted in reduced left ventricular filling pressures at mild exertion and improved exercise performance.REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03537183.
AB - BACKGROUND: Patients with hypertrophic cardiomyopathy without left ventricular outflow tract obstruction commonly experience reduced exercise capacity. Physical training improves exercise capacity in these patients, but whether the underlying effects of exercise are a result of central hemodynamic or peripheral improvement is unclear. This study assessed whether exercise training reduces left ventricular filling pressure measured during exercise in patients with hypertrophic cardiomyopathy without left ventricular outflow tract obstruction.METHODS: Between March 2019 and June 2022, patients with hypertrophic cardiomyopathy without left ventricular outflow tract obstruction were randomly assigned (1:1) to a 12-week (3 h/wk) supervised, moderate-intensity exercise training program or continued usual activity. The primary outcome was the change in invasively measured pulmonary capillary wedge pressure during mild exercise (25 W) from baseline to week 12. Pressure tracings were analyzed offline by a blinded investigator. Secondary outcomes included changes in peak oxygen consumption, cardiac index, quality of life, echocardiographic indices of diastolic function, and natriuretic peptides.RESULTS: Of 59 patients randomized (mean age, 58.1 [12.2] years; 27% women), 51 (86%) completed all follow-up assessments. At week 12, the change in 25-W pulmonary capillary wedge pressure was -2.8 (6.8) mm Hg in the exercise group, compared with +1.2 (4.9) mm Hg in the usual-activity group (between-group difference, 4.0 mm Hg [95% CI, 0.7-7.3];
P=0.018). Peak oxygen consumption improved by +1.8 (2.0) mL·kg⁻¹·min⁻¹ in the exercise group versus -0.3 (3.1) mL·kg⁻¹·min⁻¹ in the usual-activity group (
P=0.005). Exercise training improved the ventilatory efficiency (V
E/VCO
2) slope compared with usual activity (between-group difference, 2.0 [95% CI, 0.6-3.5];
P=0.006). Peak cardiac index improved by +0.38 (1.38) L·min⁻¹·m⁻² in exercise versus -0.85 (1.20) L·min⁻¹·m⁻² in the usual-activity group (
P=0.002). Change in overall Kansas City Cardiomyopathy Questionnaire score was similar between groups. However, the change in physical limitation scores (+8.4 [12.0] points in exercise versus +0.7 [6.8] points in usual-activity group;
P=0.034) and quality-of-life scores (+8.7 [18.0] points in exercise versus 0.7 [4.0] points in usual-activity group;
P=0.01) differed significantly. There were no significant changes in diastolic function assessed by echocardiography or in natriuretic peptides.
CONCLUSIONS: In patients with hypertrophic cardiomyopathy without left ventricular outflow tract obstruction, a 12-week moderate-intensity exercise training program resulted in reduced left ventricular filling pressures at mild exertion and improved exercise performance.REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03537183.
KW - Aged
KW - Cardiomyopathy, Hypertrophic/therapy
KW - Exercise Therapy/methods
KW - Exercise Tolerance
KW - Exercise/physiology
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Oxygen Consumption
KW - Pulmonary Wedge Pressure
KW - Quality of Life
KW - Treatment Outcome
KW - Ventricular Function, Left
KW - Ventricular Outflow Obstruction, Left
KW - Ventricular Outflow Obstruction/physiopathology
KW - Cardiomyopathy, hypertrophic
KW - Pulmonary wedge pressure
KW - Quality of life
KW - Exercise
U2 - 10.1161/CIRCULATIONAHA.124.070064
DO - 10.1161/CIRCULATIONAHA.124.070064
M3 - Article
C2 - 39513255
SN - 0009-7322
VL - 151
SP - 132
EP - 144
JO - Circulation
JF - Circulation
IS - 2
ER -